El Suplemento, the organizer of Premios Tecnológia Siglo XXI 2018, has awarded SOM Biotech in the Hito Tecnológico (Technological Milestone) category for the company’s commitment to achieve medical advances for the benefit of different orphan diseases, and for its exponential growth during the past year. SOM Biotech CEO, Dr. Raúl Insa, received the award at the Gala held in Madrid on February 15th …
Category Archives: News
To show its support for raising public awareness of rare diseases, SOM Biotech joins the Rare Disease Day 2018 campaign by painting faces, taking pictures and sharing them on various social media platforms. Not only does the campaign promote rare disease awareness, but also fosters fellowship among the team members. #ShowYourRare Rare Disease Day is the international awareness-raising campaign for …
Since 2008, World Rare Disease Day is celebrated on the last day of February each year. This event aims to raise public awareness of rare diseases and promote engagement among patients, associations, researchers , decision-makers and other stakeholders. SOM Biotech, a private pharmaceutical company focused on drug repurposing for neurological rare diseases, will join in …
SOM Biotech CEO, Dr. Raúl Insa, will attend the Biotech & Money Congress in London on 5th-7th of February. Dr. Insa will have the opportunity to present the company at the event and meet prospective investors and notable people in the industry. If you want to arrange a meeting with Dr. Insa, send an email …
Tras los resultados obtenidos durante el primer año de colaboración, la Asociación Duchenne Parent Project España (DPPE) confía nuevamente en la compañía Biofarmacéutica SOM Biotech prolongando el acuerdo de colaboración para llevar a cabo el proyecto “Reposicionamiento de Fármacos para la Distrofia Muscular de Duchenne (DMD)”. El equipo de SOM Biotech ha concluido satisfactoriamente la …
As 2017 comes to a close, it is a great time of year for business to reflect on the achievements and the short comings versus the goals set out at the beginning of the year. This year has been a landmark year for SOM Biotech, shifting gear from an early stage company to growth phase …
The 8th annual World Orphan Drug Congress was held in Barcelona on 13-15th of November 2017. SOM Biotech’s CEO, Dr. Raúl Insa, did a “Pitch & Partner” session on Drug Repurposing in CNS Orphan Indications. The World Orphan Drug Congress is the marketplace for orphan drug professionals looking at the complete value chain of orphan drug …
Dr. Raúl Insa (CEO) and Raj Airey (Chief Strategy Officer) had the opportunity to discuss SOM’s current programs at Europe´s largest life science partnering conference Bio-Europe 2017, that was held in Berlin November 6-9, 2017. BIO-Europe’s world-class workshops, panels and active exhibition along with thousands of pre-scheduled one-to-one meetings make this event an unrivaled forum …
Dr. Ferruccio Palazzesi, SOM Biotech Senior Computational Chemist, attended the International Symposium on “Rare diseases and big data, from research to clinical practice”, organized by Bioinformatics Barcelona Association (BIB) and Fundación Ramon Areces. Event took place in Barcelona 26-27th October 2017. The symposium covered clinical management of rare diseases, as well as current research and …
Using the latest modular workflow technologies, SOM Biotech has released a new version of his proprietary drug repurposing virtual process. This update has had the goal to improve more than 30% the performance, scalability and velocity of the process. This software update highlights the SOM Biotech strong commitment to grow day-by-day, in order to continue …